204714-20-5Relevant articles and documents
1,2,4-Triazolato paddlewheel dibismuth complexes with very short Bi(ii)-Bi(ii) bonds: Bismuth(iii) oxidation of 1,2,4-triazolato anions into neutral: N -1,2,4-triazolyl radicals
He, Ru-Ru,Li, Li,Ma, Jian-Ping,Su, Ji-Hu,Zhang, Xiang,Zhao, Ming-Gang,Zheng, Wenjun
supporting information, p. 15190 - 15194 (2020/11/18)
Bismuth(iii) oxidation of 3,5-di-substituted-1,2,4-triazolato anions afforded a paddlewheel 1,2,4-triazolato dibismuth complex [L2(Bi-Bi)L2] (L = η1,η1-3,5-R2tz, R = Ph (3), iPr (4)) with very short Bi(ii)-Bi(ii) bonds (2.8650(4)-2.8721(3) ?). The reaction involved the intermediates of the organobismuth radical [Bi(R2tz)2] and neutral N-1,2,4-triazolyl radical [3,5-R2tz]. The dimerization of the former produced the corresponding dibismuth complex while the latter was trapped by using spin trap 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) to give the radical adduct of {(3,5-R2tz)(DMPO)} which was unambiguously evidenced by EPR analysis.
A new μ4-Oxo tetranuclear magnesium compound: Coordination effects of the azolato ligands
Moesch-Zanetti, Nadia C.,Ferbinteanu, Marilena,Magull, Joerg
, p. 950 - 956 (2007/10/03)
The μ4-OXO tetranuclear magnesium compound [Mg4(μ4-oxo)(μ-tz)6] 1 (tz = 3,5-iPr2-1,2,4-triazolato) with six η1-η1-bridging triazolato ligands was prepared in a one-step reaction between MgBr2 and tzK. The solid state structure was determined by X-ray diffraction analysis showing the tetrahedral arrangement of the MG4O core. The reaction of MgBr2 with pzK and pzH gave [Mg(pz)2(pzH)2 2 (pz = 3,5-tBu2-pyrazolato), which contains hydrogen bonds between two different ligands, as established by X-ray crystal structure analysis. In solution, compound 2 shows a dynamic behavior involving two different processes. Line shape analysis of variable temperature NMR experiments suggests that the interconversion occurs via an η2-coordination of the pyrazolato ligand. Wiley-VCH Verlag GmbH, 69451 Weinheim, Germany, 2002.
2,4-Dioxopyrrolidine and 2,4-dioxotetrahydrofan derivatives and medicines containing the same at the active ingredient
-
, (2008/06/13)
Compounds including 1-(biphenyl-4-yl)methyl-1H-1,2,4-triazoles and 1-(biphenyl-4-yl)methyl-4H-1,2,4-triazoles each having a (2,4-dioxopyrrolidine-5-ylidene)methyl or (2,4-dioxo-tetrahydrofiuran-5-ylidene)methyl group as the substituent at the 2′-position and salts thereof are lowly toxic and highly safe and are useful as an angiotensin II antagonist. Thus, these compounds can be used in medicines, which contain these compounds as an active ingredient.